4-186621773-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005245.4(FAT1):​c.4813A>G​(p.Asn1605Asp) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00264 in 1,550,142 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 50 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 39 hom. )

Consequence

FAT1
NM_005245.4 missense, splice_region

Scores

3
7
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 8.02

Publications

6 publications found
Variant links:
Genes affected
FAT1 (HGNC:3595): (FAT atypical cadherin 1) This gene is an ortholog of the Drosophila fat gene, which encodes a tumor suppressor essential for controlling cell proliferation during Drosophila development. The gene product is a member of the cadherin superfamily, a group of integral membrane proteins characterized by the presence of cadherin-type repeats. In addition to containing 34 tandem cadherin-type repeats, the gene product has five epidermal growth factor (EGF)-like repeats and one laminin A-G domain. This gene is expressed at high levels in a number of fetal epithelia. Its product probably functions as an adhesion molecule and/or signaling receptor, and is likely to be important in developmental processes and cell communication. Transcript variants derived from alternative splicing and/or alternative promoter usage exist, but they have not been fully described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006181717).
BP6
Variant 4-186621773-T-C is Benign according to our data. Variant chr4-186621773-T-C is described in ClinVar as Benign. ClinVar VariationId is 778168.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0133 (2032/152266) while in subpopulation AFR AF = 0.0469 (1946/41520). AF 95% confidence interval is 0.0451. There are 50 homozygotes in GnomAd4. There are 942 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 50 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAT1NM_005245.4 linkc.4813A>G p.Asn1605Asp missense_variant, splice_region_variant Exon 10 of 27 ENST00000441802.7 NP_005236.2 Q14517
FAT1NM_001440456.1 linkc.4813A>G p.Asn1605Asp missense_variant, splice_region_variant Exon 10 of 28 NP_001427385.1
FAT1NM_001440457.1 linkc.4813A>G p.Asn1605Asp missense_variant, splice_region_variant Exon 10 of 28 NP_001427386.1
FAT1NM_001440455.1 linkc.4813A>G p.Asn1605Asp missense_variant, splice_region_variant Exon 10 of 27 NP_001427384.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAT1ENST00000441802.7 linkc.4813A>G p.Asn1605Asp missense_variant, splice_region_variant Exon 10 of 27 5 NM_005245.4 ENSP00000406229.2 Q14517

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
2017
AN:
152148
Hom.:
48
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0466
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00379
AC:
678
AN:
178806
AF XY:
0.00286
show subpopulations
Gnomad AFR exome
AF:
0.0497
Gnomad AMR exome
AF:
0.00187
Gnomad ASJ exome
AF:
0.000726
Gnomad EAS exome
AF:
0.0000683
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000273
Gnomad OTH exome
AF:
0.00178
GnomAD4 exome
AF:
0.00148
AC:
2067
AN:
1397876
Hom.:
39
Cov.:
32
AF XY:
0.00127
AC XY:
875
AN XY:
689924
show subpopulations
African (AFR)
AF:
0.0513
AC:
1612
AN:
31432
American (AMR)
AF:
0.00220
AC:
74
AN:
33604
Ashkenazi Jewish (ASJ)
AF:
0.000760
AC:
18
AN:
23678
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38950
South Asian (SAS)
AF:
0.0000517
AC:
4
AN:
77404
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48026
Middle Eastern (MID)
AF:
0.00670
AC:
37
AN:
5522
European-Non Finnish (NFE)
AF:
0.000144
AC:
156
AN:
1081476
Other (OTH)
AF:
0.00287
AC:
166
AN:
57784
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
100
200
300
400
500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0133
AC:
2032
AN:
152266
Hom.:
50
Cov.:
33
AF XY:
0.0127
AC XY:
942
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0469
AC:
1946
AN:
41520
American (AMR)
AF:
0.00334
AC:
51
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68028
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
89
178
268
357
446
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00443
Hom.:
54
Bravo
AF:
0.0148
ESP6500AA
AF:
0.0368
AC:
131
ESP6500EA
AF:
0.000253
AC:
2
ExAC
AF:
0.00367
AC:
439
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 31, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.52
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.40
T;T
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.95
D;T
MetaRNN
Benign
0.0062
T;T
MetaSVM
Benign
-0.73
T
MutationAssessor
Benign
1.3
L;.
PhyloP100
8.0
PrimateAI
Uncertain
0.69
T
PROVEAN
Pathogenic
-4.7
D;.
REVEL
Uncertain
0.35
Sift
Uncertain
0.0070
D;.
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
0.83
MVP
0.44
MPC
0.53
ClinPred
0.024
T
GERP RS
5.1
Varity_R
0.69
gMVP
0.41
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6836935; hg19: chr4-187542927; COSMIC: COSV99081606; API